Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.09% |
| 2 | Healthcare | 5.36% |
| 3 | Financials | 5.34% |
| 4 | Communication Services | 4.69% |
| 5 | Consumer Discretionary | 4.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GES
3651
PUT
DELISTED
Guess Inc
GES
| $555K | ﹤0.01% |
26,700
-5,800
| -18% | -$123K |
|
3652
Puma Biotechnology
PBYI
$450M
| $555K | ﹤0.01% |
27,259
-100,852
| -79% | -$3.03M |
|
3653
CALL
iShares Core S&P 500 ETF
IVV
$910B
| $554K | ﹤0.01% |
2,200
+900
| +69% | +$244K |
|
3654
Tyler Technologies
TYL
$13.5B
| $554K | ﹤0.01% |
2,980
-10,781
| -78% | -$2.13M |
|
|
BKS
3655
CALL
DELISTED
Barnes & Noble
BKS
| $551K | ﹤0.01% |
77,700
+75,900
| +4,217% | +$507K |
|
3656
PUT
Iron Mountain
IRM
$37B
| $548K | ﹤0.01% |
16,900
+7,500
| +80% | +$246K |
|
3657
Benchmark Electronics
BHE
$2.94B
| $547K | ﹤0.01% |
25,842
-55,545
| -68% | -$1.28M |
|
3658
VEON
VEON
$3.92B
| $547K | ﹤0.01% |
9,350
+5,713
| +157% | +$386K |
|
|
NE
3659
DELISTED
Noble Corporation
NE
| $547K | ﹤0.01% |
208,752
-470,277
| -69% | -$2.23M |
|
|
AKS
3660
CALL
DELISTED
AK Steel Holding Corp
AKS
| $546K | ﹤0.01% |
242,900
-36,500
| -13% | -$132K |
|
3661
Ceragon Networks
CRNT
$198M
| $545K | ﹤0.01% |
144,223
-6,825
| -5% | -$25.9K |
|
3662
MYR Group
MYRG
$5.18B
| $543K | ﹤0.01% |
19,273
+470
| +2% | +$14.5K |
|
3663
National Presto Industries
NPK
$998M
| $542K | ﹤0.01% |
4,637
-1,736
| -27% | -$217K |
|
|
CRZO
3664
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $541K | ﹤0.01% |
47,900
+3,200
| +7% | +$56.9K |
|
3665
PUT
Enterprise Products Partners
EPD
$82.1B
| $539K | ﹤0.01% |
21,900
-13,900
| -39% | -$372K |
|
|
FIT
3666
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $539K | ﹤0.01% |
108,500
+4,900
| +5% | +$25.3K |
|
3667
PUT
American Tower
AMT
$79.4B
| $538K | ﹤0.01% |
3,400
-2,500
| -42% | -$391K |
|
3668
Zurn Elkay Water Solutions
ZWS
$8.41B
| $538K | ﹤0.01% |
48,595
-429,078
| -90% | -$5.56M |
|
|
PTE
3669
CALL
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $538K | ﹤0.01% |
+1,596
| New | +$577K |
|
|
ONCE
3670
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $538K | ﹤0.01% |
13,752
-4,742
| -26% | -$206K |
|
3671
CALL
Core Laboratories
CLB
$571M
| $537K | ﹤0.01% |
9,000
+5,000
| +125% | +$431K |
|
3672
S&T Bancorp
STBA
$1.82B
| $537K | ﹤0.01% |
14,176
-27,472
| -66% | -$1.11M |
|
|
MDRX
3673
DELISTED
Veradigm Inc. Common Stock
MDRX
| $537K | ﹤0.01% |
55,691
-95,283
| -63% | -$1.06M |
|
|
RETA
3674
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $537K | ﹤0.01% |
9,584
+2,511
| +36% | +$153K |
|
|
ECOM
3675
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $537K | ﹤0.01% |
47,345
+17,009
| +56% | +$191K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 8.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.